Achmea Investment Management B.V. Qiagen N.V. Transaction History

Achmea Investment Management B.V.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$45.29 - $50.76 $992,666 - $1.11 Million	-21,918 Reduced 59.18%	15,117 $689,000
Q4 2022 Feb 09, 2023	SELL	$41.91 - $50.48 $363,988 - $438,418	-8,685 Reduced 19.0%	37,035 $1.74 Million
Q3 2022 Oct 27, 2022	BUY	$40.9 - $50.42 $73,251 - $90,302	1,791 Added 4.08%	45,720 $1.93 Million
Q2 2022 Aug 10, 2022	BUY	$42.98 - $49.77 $156,877 - $181,660	3,650 Added 9.06%	43,929 $2.05 Million
Q1 2022 May 16, 2022	BUY	$42.23 - $54.3 $1.7 Million - $2.19 Million	40,279 New	40,279 $2 Million
Q4 2021 Feb 10, 2022	SELL	$50.62 - $56.47 $1.23 Million - $1.38 Million	-24,364 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$46.55 - $56.83 $858,475 - $1.05 Million	-18,442 Reduced 43.08%	24,364 $1.26 Million
Q2 2021 Aug 06, 2021	SELL	$46.28 - $52.75 $496,538 - $565,954	-10,729 Reduced 20.04%	42,806 $2.07 Million
Q1 2021 May 11, 2021	BUY	$46.25 - $56.02 $854,283 - $1.03 Million	18,471 Added 52.68%	53,535 $2.6 Million
Q4 2020 Feb 22, 2021	BUY	$46.09 - $54.74 $1.26 Million - $1.5 Million	27,423 Added 358.89%	35,064 $1.82 Million
Q3 2020 Nov 02, 2020	BUY	$42.51 - $52.42 $324,818 - $400,541	7,641 New	7,641 $396,000

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.5B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

Stay updated on Achmea Investment Management B.V. with notifications on news.